Rethinking/transcending the red-blue, left-right, secular-religious and related divides, domestically and globally
By Richard Hayes,
U .C. Berkeley College of Natural Resources/Energy and Resources Group
| 02. 25. 2013
This short note introduces the third topic I want to address during my time at ERG this year. It follows necessarily on the first topic addressing scenarios of economic growth, economic justice and ecological integrity, and on the second topic addressing global governance of profoundly consequently new technologies.
It’s difficult but not impossible to construct scenarios of the human future over the next 100-200 years that most people would likely agree represent a path towards a just, sustainable, vital and fully human world. The difficulty is that real-world initiatives to craft, adopt, implement and maintain the policies and programs that would realize these scenarios require a degree of global consensus, unity and commitment, between and within countries, regions, and populations, of truly unprecedented scope, scale and duration. Further, we need more than just policies and programs - we need hearts and minds. We need a deeply internalized shared vision of where we are going, of how we are to live our lives and how we are to regard and treat one another, and why. We need a new vision of...
Related Articles
Not the species, certainly, but the Institute of that name, which was founded by transhumanist philosopher Nick Bostrom in 2005 as a research group at Oxford University. According to a recently posted Final Report, its goal was “to pursue the big questions in a transdisciplinary way” by pulling together “researchers from disciplines such as philosophy, computer science, mathematics, and economics.” This evolved before long into the study and promotion of “effective altruism” and “longtermism” as...
By Tristan Manalac, BioSpace | 04.02.2024
Verve Therapeutics has suspended enrollment in the Phase Ib Heart-1 study evaluating its lead gene editing program VERVE-101 following a serious adverse event, the company announced Tuesday.
A patient, who received a 0.45-mg/kg dose of VERVE-101, developed a grade 3...
By Timnit Gebru and Émile P. Torres, First Monday | 04.14.2024
The stated goal of many organizations in the field of artificial intelligence (AI) is to develop artificial general intelligence (AGI), an imagined system with more intelligence than anything we have ever seen. Without seriously questioning whether such a system can...
By Harold Brubaker, The Philadelphia Inquirer | 04.04.2024
Acompany started by University of Pennsylvania scientist Jim Wilson has received FDA approval to test a form of gene editing in infants for the first time in the United States, the company said Thursday.
The Plymouth Meeting company, iECURE, is...